ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Neuropeptides ∟ Angiotensins ∟ Angiotensin II 3 coordinate concepts 3 subordinate concepts ∟ 1-Sarcosine-8-Isoleucine Angiotensin II \| ∟ Angiotensin Amide \| ∟ Saralasin ∟ Angiotensin I \| ∟ Angiotensin III \| ∟ Angiotensinogen Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Oligopeptides ∟ Angiotensins ∟ Angiotensin II 3 coordinate concepts 3 subordinate concepts ∟ 1-Sarcosine-8-Isoleucine Angiotensin II \| ∟ Angiotensin Amide \| ∟ Saralasin ∟ Angiotensin I \| ∟ Angiotensin III \| ∟ Angiotensinogen Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Proteins ∟ Nerve Tissue Proteins ∟ Neuropeptides ∟ Angiotensins ∟ Angiotensin II 3 coordinate concepts 3 subordinate concepts ∟ 1-Sarcosine-8-Isoleucine Angiotensin II \| ∟ Angiotensin Amide \| ∟ Saralasin ∟ Angiotensin I \| ∟ Angiotensin III \| ∟ Angiotensinogen Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Autacoids ∟ Angiotensins ∟ Angiotensin II 3 coordinate concepts 3 subordinate concepts ∟ 1-Sarcosine-8-Isoleucine Angiotensin II \| ∟ Angiotensin Amide \| ∟ Saralasin ∟ Angiotensin I \| ∟ Angiotensin III \| ∟ Angiotensinogen X
Broader terms:	Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Neuropeptides ∟ Angiotensins ∟ Angiotensin II Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Peptides ∟ Oligopeptides ∟ Angiotensins ∟ Angiotensin II Medical Subject Headings (MeSH) ∟ Amino Acids, Peptides, and Proteins ∟ Proteins ∟ Nerve Tissue Proteins ∟ Neuropeptides ∟ Angiotensins ∟ Angiotensin II Medical Subject Headings (MeSH) ∟ Biological Factors ∟ Inflammation Mediators ∟ Autacoids ∟ Angiotensins ∟ Angiotensin II Angiotensins > Neuropeptides > Peptides > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Angiotensins > Oligopeptides > Peptides > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Angiotensins > Neuropeptides > Nerve Tissue Proteins > Proteins > Amino Acids, Peptides, and Proteins > Medical Subject Headings (MeSH) Angiotensins > Autacoids > Inflammation Mediators > Biological Factors > Medical Subject Headings (MeSH) X
Narrower terms:	1-Sarcosine-8-Isoleucine Angiotensin II \| Angiotensin Amide \| Saralasin X
historyNote*:	1974(1963); for ANGIOTENSIN II, ILE(5)- use ANGIOTENSIN II (NM) 1974-1999 X
publicMeSHNote*:	1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 (HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973); ANGIOTENSIN II, ILE(5)- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981 X
Scope note:	The active form of angiotensin. An octapeptide found in blood, it is synthesized from ANGIOTENSIN I and quickly destroyed. Angiotensin II causes profound vasoconstriction with a resulting increase in blood pressure. It differs among species by the amino acid in position 5. The human form has ISOLEUCINE in this position. The clinically and experimentally used bovine form has VALINE in position 5. Medically useful antagonism is obtained with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. X
activeMeSHYear*:	2007X
dateCreated*:	1999-01-01X
dateRevised*:	2006-07-05X
recordAuthorizer*:	sjnX
recordMaintainer*:	agsX
recordOriginator*:	NLMX
Related term:	Renin-Angiotensin System X
Type:	Concept X
Coordinate terms:	Angiotensin I \| Angiotensin III \| Angiotensinogen X
URI:	X
Labels and equivalent concepts:	Angiotensiini (fi) Angiotensiini II (fi, replaced) Angiotensiini-II (fi, replaced) Isoleucyl(5)-Angiotensin II (en, replaced) Valyl(5)-Angiotensin II (en, replaced) Isoleucine(5)-Angiotensin (en, replaced) Angiotensin-(1-8) Octapeptide (en, replaced) ANG-(1-8)Octapeptide (en, replaced) Angiotensin II, Isoleucine(5)- (en, replaced) Angiotensin II, Valine(5)- (en, replaced) 5-L-Isoleucine Angiotensin II (en, replaced) X
Share:	X